Alvotech ALVO
NASDAQ ALVO
$5.21 +0.02 (+0.38%)
As of: Sep 9, 2026 · 3:59 PM EDT

Alvotech (ALVO) Total Current Liabilities (2020 - 2026)

Alvotech's (ALVO) quarterly Total Current Liabilities came in at $331.2 million in Q2 2026, up 18.38% on a YoY basis from $279.7 million in Q2 2025, and up 27.48% quarter-over-quarter from $259.8 million in Q1 2026.

Analysis

Alvotech (ALVO) Total Current Liabilities (2020 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Total Current Liabilities for 7 consecutive years, with $331.2 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Total Current Liabilities rose 18.38% year-over-year to $331.2 million; the trailing twelve-month figure through Jun 2026 stood at $331.2 million (up 18.38% YoY), and the FY2025 full-year result was $304.1 million, up 57.23% from the prior year.
  • Total Current Liabilities rose to $331.2 million in Q2 2026 per ALVO's latest filing, from $259.8 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $1.2 billion in Q2 2024 and bottomed at $160.5 million in Q3 2024.
  • Historically, Total Current Liabilities has averaged $319.7 million across 5 years, with a median of $263.4 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Total Current Liabilities soared 442.4% in 2024, then plunged 76.74% in 2025.
  • Over 5 years, Total Current Liabilities stood at $167.3 million in 2022, then soared by 55.98% to $261.0 million in 2023, then fell by 25.89% to $193.4 million in 2024, then soared by 57.23% to $304.1 million in 2025, then climbed by 8.91% to $331.2 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $331.2 million, $259.8 million, and $304.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn 15.65 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn 6.35 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn 1.66 Bn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn 883.19 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn 4.54 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn 283.66 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn 331.18 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn 263.21 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn 12.39 Mn
10 NutriBand 72.57 Mn 69.15 Mn 181,874.00 907,048.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 331.18 Mn
Mar 31, 2026 259.78 Mn
Dec 31, 2025 304.08 Mn
Sep 30, 2025 304.07 Mn
Jun 30, 2025 279.75 Mn
Mar 31, 2025 265.81 Mn
Dec 31, 2024 193.40 Mn
Sep 30, 2024 160.55 Mn
Jun 30, 2024 1.20 Bn
Mar 31, 2024 246.79 Mn
Dec 31, 2023 260.95 Mn
Jun 30, 2023 221.69 Mn
Dec 31, 2022 167.29 Mn
Jun 30, 2022 277.79 Mn
Dec 31, 2021 111.84 Mn
Dec 31, 2020 50.98 Mn